Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jacobi

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Acta Physiologica (Oxford, England)|March 11, 2022
Old pathways - New crossroads: Class 3 PI3K acts on glucocorticoid signal transductionDavid Jacobi
The Journal of ECT|July 10, 2024
Reply to "Glucagon-Like Peptide-1 Receptor Agonists During Electroconvulsive Therapy: Case Report With Evolving Concerns and Management Considerations"David Jacobi
La Revue Du Praticien|April 29, 2008
[National ranking exam. N65. What could come up in the exam?]David Jacobi, Charles Couet
The Journal of Clinical Endocrinology and Metabolism|December 18, 2025
Timing matters: daytime activity, nighttime rest, and MASLD riskSarra Smati, David Jacobi
La Revue Du Praticien|April 17, 2007
[Nutritional needs and food supplements in the adult. Evaluation of the nutritional state. Malnutrition]David Jacobi, Charles Couet
Annales D'Endocrinologie|December 15, 2023
Precision medicine in endocrinology: Unraveling metabolic health through time-restricted eatingAlbane Chavanne, David Jacobi
Presse Medicale (Paris, France : 1983)|July 29, 2010
[Are we facing an obesity pandemic?]David Jacobi, Rodolphe Buzelé, Charles Couet
Obesity Surgery|March 4, 2024
Adjuvant Glucose-Like Peptide 1 Receptor Agonist Therapy for Suboptimal Weight Loss After Bariatric Surgery: a Systematic ReviewAlexandre Dréant, Claire Blanchard, David Jacobi
Obesity Surgery|February 19, 2021
Daily Timing of Meals and Weight Loss After Bariatric Surgery: a Systematic ReviewMarine Cossec, Florian Atger, Claire Blanchard, et al.
Adipocyte|August 24, 2012
Adipose tissue signaling by nuclear receptors in metabolic complications of obesityDavid Jacobi, Kristopher J Stanya, Chih-Hao Lee
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Acta Physiologica (Oxford, England)|March 11, 2022
Old pathways - New crossroads: Class 3 PI3K acts on glucocorticoid signal transductionDavid Jacobi
The Journal of ECT|July 10, 2024
Reply to "Glucagon-Like Peptide-1 Receptor Agonists During Electroconvulsive Therapy: Case Report With Evolving Concerns and Management Considerations"David Jacobi
La Revue Du Praticien|April 29, 2008
[National ranking exam. N65. What could come up in the exam?]David Jacobi, Charles Couet
The Journal of Clinical Endocrinology and Metabolism|December 18, 2025
Timing matters: daytime activity, nighttime rest, and MASLD riskSarra Smati, David Jacobi
La Revue Du Praticien|April 17, 2007
[Nutritional needs and food supplements in the adult. Evaluation of the nutritional state. Malnutrition]David Jacobi, Charles Couet
Annales D'Endocrinologie|December 15, 2023
Precision medicine in endocrinology: Unraveling metabolic health through time-restricted eatingAlbane Chavanne, David Jacobi
Presse Medicale (Paris, France : 1983)|July 29, 2010
[Are we facing an obesity pandemic?]David Jacobi, Rodolphe Buzelé, Charles Couet
Obesity Surgery|March 4, 2024
Adjuvant Glucose-Like Peptide 1 Receptor Agonist Therapy for Suboptimal Weight Loss After Bariatric Surgery: a Systematic ReviewAlexandre Dréant, Claire Blanchard, David Jacobi
Obesity Surgery|February 19, 2021
Daily Timing of Meals and Weight Loss After Bariatric Surgery: a Systematic ReviewMarine Cossec, Florian Atger, Claire Blanchard, et al.
Adipocyte|August 24, 2012
Adipose tissue signaling by nuclear receptors in metabolic complications of obesityDavid Jacobi, Kristopher J Stanya, Chih-Hao Lee
Pageof 6